Policyholder Services

Will OMIC cover me for implantation of a multifocal intraocular lens?

Updated 10/2/2019

Yes. OMIC covers claims against insured ophthalmologists who implant multifocal intraocular lenses in conjunction with cataract surgery or refractive lens exchange (RLE) (subject to standard policy terms and conditions). While multifocal intraocular lenses are FDA-approved for use in cataract surgery, they are used off-label for RLE. OMIC requires that surgeons advise RLE patients of this off-label use.

Risk Management Advice: OMIC recommends that the surgeon discuss with the patient the option of monovision with monofocal implants, demonstrate monovision in the office with contact lenses, and document that the patient does not accept this alternative. OMIC also recommends that the surgeon discuss with the patient the less expensive option of undergoing surgery with treatment of both eyes for distance, with continued use of reading glasses following surgery. Discussion of both options and demonstration of monovision should be carefully documented in the patient’s medical record. OMIC believes that the discussion and demonstration of monovision as an option is an important component of a complete informed consent process and that it should be done on all patients considering multifocal intraocular lenses. As discussed above, surgeons must advise patients of the off-label use of multifocal lenses for RLE. OMIC recommends that physicians document this discussion in the patient’s medical record and informed consent form.

Please refer to OMIC's Copyright and Disclaimer regarding the contents on this website

Leave a comment

Six reasons OMIC is the best choice for ophthalmologists in America.

Consistent return of premium.

Publicly-traded insurance companies exist to make profits for shareholders while physician-owned carriers often return profits to their policyholders. Don’t underestimate this benefit; it can add up to tens of thousands of dollars over the course of your career. OMIC has one of the most generous dividend programs for ophthalmologists and has returned more than $90 Million to our members through dividends.